Facebook Instagram Linkedin Youtube
Home Tags ELC-301

Tag: ELC-301

Adjutec prepares for clinical trial

Elicera’s first clinical CAR T-Cell study CARMA set to begin

Full speed ahead for Elicera in 2024

Full speed ahead for Elicera in 2024

Elicera's CEO: " iTANK has great potential in treating solid tumours"

Elicera’s CEO: ” iTANK has great potential in treating solid tumours”

Elicera_EU_patent

Elicera Therapeutics receives important EU patent

Elicera uppdaterar i samband med Cancer Immunotherapy Month

Elicera gives an update in Cancer Immunotherapy Month

Elicera Q1 2023

Well-financed Elicera prepared for clinic and business development

Janssen CAR T deal supports Elicera’s vision

Janssen CAR T deal supports Elicera’s vision

Elicera Q4 2022

Advancements for Elicera in 2022 open for intensive clinical year

Elicera comments on AstraZeneca acquisition of Neogene Therapeutics

Elicera on AstraZeneca’s acquisition of Neogene Therapeutics

Elicera fas I signaler

Elicera on the positive clinical effect in cancer trial

12Page 1 of 2
© BioStock 2024